ARTO trial: Overall survival analysis from a randomized phase II trial testing the benefit of adding stereotactic body radiotherapy to abiraterone acetate in patients with oligometastatic castrate-resistant prostate cancer.

Autor: Francolini, Giulio, Di Cataldo, Vanessa, Garlatti, Pietro, Detti, Beatrice, Caini, Saverio, Bruni, Alessio, Ingrosso, Gianluca, D'Angelillo, Rolando Maria, Alitto, Anna Rita, Augugliaro, Matteo, Triggiani, Luca, Parisi, Silvana, Facchini, Gaetano, Banini, Marco, Simontacchi, Gabriele, Desideri, Isacco, Meattini, Icro, Valicenti, Richard K., Livi, Lorenzo
Zdroj: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p132-132, 235p
Databáze: Supplemental Index